Aim Bulletin
AB Dynamics shares jump as six-month profits double
AB Dynamics nearly doubled its profits over the first half, even as it continued to expand its international footprint and invest for the future.
Sunrise Resources makes progress with various projects
Sunrise Resources updated the market on some of its projects on Wednesday, saying that at the CS Pozzolan-Perlite Project, the latest testwork showed “promise” for the production of premium-value super-coarse horticultural grades of perlite.
PetroNeft confirms new reserves in Cheremshanskoye field
Russia-focussed oil and gas exploration and production company PetroNeft updated the market on its 50%-owned licence 67 on Wednesday, reporting that new reserves had been approved for the licence in the Cheremshanskoye field.
Ixico signs on two new biopharmaceutical clients
Data analytics company Ixico has signed contracts with two biopharmaceutical companies to provide its technology-enabled imaging services to support an early phase study in Huntington's disease (HD), and a phase 3 study in another rare neurological disease.
Diurnal gets orphan drug designation for Alkindi in Australia
Specialty pharmaceutical company Diurnal Group announced on Wednesday that its ‘Alkindi’ product - hydrocortisone granules in capsules for opening - had been granted orphan drug designation in Australia by the Therapeutic Goods Administration, for the indication ‘replacement therapy of adrenal insufficiency (AI) in infants, children and adolescents from birth to 18 years old’.
Metals Exploration emerges from quarter of change
Pacific Rim-focussed natural resources exploration and development company Metals Exploration updated the market on its Runruno gold project in the Philippines on Wednesday, reporting mining of 2. 93Mt in the quarter ended 31 March, with total ore mined standing at 573Kt.
Beximco gets FDA approval for generic anti-allergy drug
Beximco Pharmaceuticals announced on Wednesday that it has received US Food and Drug Administration (FDA) approval for its cyproheptadine hydrochloride tablet 4mg anti-allergy drug, which is a generic equivalent to ‘Periactin’ 4mg tablets from Merck and Company.
Mi-Pay revenue boosted by fraud management launch
Mi-Pay Group's shares edged upwards on Wednesday as the company reported a reduction in annual loss as revenue crept up following the launch of its new fraud management service.
Midatech Pharma mired in losses as R&D costs mount
Midatech Pharma's shares dropped on Wednesday as the company reported an annual loss and falling cash balances, though it remained confident in its ability to create value over the next 18-24 months.
Ascent Resources raises £750,000 in oversubscribed placing
Exploration and production outfit Ascent Resources completed an oversubscribed placing of 214. 2m ordinary shares on Wednesday.
OptiBiotix to launch SlimBiome Medical in UK market this month
Life sciences business OptiBiotix Health announced the launch of its weight management product ‘SlimBiome Medical’ to the UK market on Wednesday.
Gama Aviation soars despite gloomy outlook on 'challenging' 2019
Gama Aviation shares climbed on Wednesday after the firm reported higher full-year revenue, despite describing the year as "disappointing" and taking a cautious stance on its outlook amid "challenging" European market conditions.
Biome makes 'small' profit as revenues improve on Q4
Technology group Biome saw revenues improve quarter-on-quarter, helping it carve out a small pre-tax profit.
SysGroup EBITDA in line with expectations on growing revenues
IT services and cloud hosting provider SysGroup told investors on Wednesday that both full-year revenue and adjusted EBITDA would be in line with management's expectations.
Westminster Group shares climb after $3.48m contract win
Westminster Group shares climbed on Wednesday after being awarded a $3. 48m contract for the provision of advanced container screening solutions to two separate ports in an unspecified Asian country.
Boohoo profits and revenue rise as PLT and Nasty Gal shine
Fast fashion brand Boohoo posted a jump in full-year revenue and profit on Wednesday amid growth across all three of its brands, with PrettyLittleThing a standout performer.
Trafalgar Property exchanges contracts on assisted living site
Residential and assisted living property developer Trafalgar Property has exchanged contracts to acquire a site for the development of its first assisted living scheme.